Catherine C. Turkel - Feb 9, 2023 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Stock symbol
LEXX
Transactions as of
Feb 9, 2023
Transactions value $
$4,267
Form type
4
Date filed
2/27/2023, 09:52 AM
Previous filing
Oct 13, 2022
Next filing
Jul 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX Common Shares Purchase $4.27K +1.5K $2.84 1.5K Feb 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 3.4K Feb 9, 2023 Common Shares 3.4K $3.04 Direct
holding LEXX Stock Options 5K Feb 9, 2023 Common Shares 1.6K $1.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.